FDA Inspection 1114326 — Celerion Inc
The FDA completed an inspection of Celerion Inc on November 21, 2019 in Lincoln, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 21, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lincoln, NE (United States)
Additional Details
Clinical BA/BE